The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
نویسندگان
چکیده
منابع مشابه
Alterations of the human gut microbiome in multiple sclerosis
The gut microbiome plays an important role in immune function and has been implicated in several autoimmune disorders. Here we use 16S rRNA sequencing to investigate the gut microbiome in subjects with multiple sclerosis (MS, n=60) and healthy controls (n=43). Microbiome alterations in MS include increases in Methanobrevibacter and Akkermansia and decreases in Butyricimonas, and correlate with ...
متن کاملThe gut microbiome as therapeutic target.
Obesity, type-2 diabetes and low-grade inflammation are becoming worldwide epidemics. In this regard, the literature provides a novel concept that we call "MicrObesity" (Microbes and Obesity), which is devoted to deciphering the specific role of dysbiosis and its impact on host metabolism and energy storage. In the present review, we discuss novel findings that may partly explain how the microb...
متن کاملP133: Targeting NF-Κb Signaling Pathway as Potential Therapeutic with Curcumin in Treatment of Multiple Sclerosis
Curcumin is active component of turmeric and isolated from the rhizome of turmeric, a phenolic natural product. One of inflammatory disease is multiple sclerosis, a multifocal chronic autoimmune inflammatory disease of the CNS, which is also known as a perivascular demyelinating disease. Studies have been shown that neuro-inflammation can have both harmful and beneficial effects on the neuronal...
متن کاملPPAR-γ: Therapeutic Potential for Multiple Sclerosis
The role of peroxisome proliferator-activated receptors (PPARs) in altering lipid and glucose metabolism is well established. More recent studies indicate that PPARs also play critical roles in controlling immune responses. We and others have previously demonstrated that PPAR-gamma agonists modulate the development of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple ...
متن کامل[A new therapeutic avenue for severe systemic sclerosis: imatinib mesylate].
A new therapeutic avenue for severe systemic sclerosis: imatinib mesylate A. Taïeb a,∗, J. Constans b, F.-X. Mahon c a Service de dermatologie et dermatologie pédiatrique, centre de référence pour les maladies rares de la peau, Inserm U876, CHU de Bordeaux, université Victor-Segalen–Bordeaux-II, Bordeaux, France b Service de médecine vasculaire, CHU de Bordeaux, hôpital Saint-André, 1, rue Jean...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Medical Sciences
سال: 2018
ISSN: 2076-3271
DOI: 10.3390/medsci6030069